SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549



                                   FORM 8-K
                                CURRENT REPORT

                    Pursuant to Section 13 or 15(d) of the
                        Securities Exchange Act of 1934


                              February 21, 1997
                      (Date of Earliest Event Reported)


                          GENERAL MEDICAL CORPORATION
            (Exact name of registrant as specified in its charter)


              Delaware                    33-69874           94-2640465
     (State or other jurisdiction     (Commission File     (IRS Employer
          of incorporation)                Number)        Identification
                                                              Number)


                 8471 Landmark Road, Richmond, Virginia 23228
        (Address of principal executive offices, including Zip Code)


                                (804) 264-7500
             (Registrant's telephone number, including area code)




          Item 1 - Change in Control of Registrant.

                    Pursuant to an Agreement and Plan of Merger,
          dated as of January 28, 1997 (the "Merger Agreement"), by
          and among General Medical Inc., a Delaware corporation
          ("General Medical"), McKesson Corporation, a Delaware
          corporation ("McKesson"), Spider Acquisition Corporation,
          a Delaware corporation and a wholly owned subsidiary of
          McKesson ("Merger Sub"), and certain stockholders of
          General Medical named therein (the "Continuing
          Stockholders"), Merger Sub has been merged with and into
          General Medical (the "Merger"), with General Medical as
          the surviving corporation in the Merger.  The Merger,
          which became effective on February 21, 1997, may be
          deemed to constitute a change in control of the
          Registrant, which is an indirect wholly-owned subsidiary
          of General Medical.  A copy of the Merger Agreement is
          filed herewith as Exhibit 2.1 and is incorporated herein
          by reference.

                    Pursuant to the Merger, each share of General
          Medical held by the Continuing Stockholders formerly
          representing the shares of General Medical common stock,
          par value $.01 per share (the "Common Stock") and/or the
          shares of Class A Common Stock, par value $.01 per share
          (the "Class A Common Stock" and together with the Common
          Stock, the "Shares"), was converted in the Merger into
          the right to receive (i) 0.289 shares of the common
          stock, par value $.01 per share of McKesson, together
          with the associated Preferred Stock Purchase Rights of
          McKesson (collectively the "McKesson Common Stock"); (ii)
          an amount in cash equal to $11.934; (iii) the
          Distribution Amount (as determined in the Merger
          Agreement) upon the distribution thereof in accordance
          with the Merger Agreement and (iv) any cash in lieu of
          fractional shares of McKesson Common Stock as provided in
          the Merger Agreement (the foregoing being collectively
          referred to as the "Merger Consideration"), subject to
          the terms and conditions of the Merger Agreement.

                    Each share of General Medical held by the
          stockholders who were not parties to the Merger Agreement
          (the "Non-Continuing Stockholders") formerly representing
          the General Medical Shares was converted into the right
          to receive (i) an amount in cash equal to $29.807 and
          (ii) the Distribution Amount (as defined in the Merger
          Agreement) upon the distribution thereof in accordance
          with the Merger Agreement, subject to the terms and
          conditions of the Merger Agreement.

                    The Distribution Amount, which is non-
          transferable, relates to $30 million of the cash
          consideration which was held back from the General
          Medical shareholders and optionholders to be applied
          against certain costs incurred by General Medical and
          certain other defendants in connection with a pending
          lawsuit involving General Medical.

                    McKesson paid approximately $347 million for
          the equity of General Medical, approximately fifty
          percent of which was in the form of 2,791,738 shares of
          the common stock of McKesson, with the balance paid in
          cash.  In addition, McKesson assumed approximately $428
          million in debt.  In connection with the acquisition,
          McKesson entered into a revolving credit facility (the
          "Credit Facility") with Bank of America National Trust
          and Savings Association (the "Bank"), dated February 21,
          1997.  Subject to the terms and conditions of the Credit
          Facility, McKesson may borrow an aggregate amount not
          exceeding $525,000,000 for the purpose of financing the
          acquisition of General Medical and working capital
          purposes related to the acquisition.  The Credit Facility
          will terminate on the earlier to occur of (i) the date
          which is 180 days after the date on which all conditions
          precedent set forth in the Credit Facility are satisfied
          or waived, and (ii) the date on which the commitment
          terminates in accordance with the provisions of the
          Credit Facility.  The Credit Facility also provides that
          each loan shall bear interest at a rate per annum equal
          to the Offshore Rate or the Base Rate, as the case may
          be, plus the Applicable Margin (as such terms are defined
          in the Credit Facility).

                    The Credit Facility contains certain covenants,
          including covenants obligating McKesson (i) to comply
          with the covenants set forth in a certain Credit
          Agreement dated as of November 4, 1996, among McKesson,
          the financial institutions party thereto, The Chase
          Manhattan Bank, and the Bank, as may be modified and
          amended, (ii) to reimburse and compensate the Bank for
          certain costs and expenses incurred under the Credit
          Facility, (iii) not to deduct any foreign taxes from any
          payments it makes to the Bank, under certain
          circumstances, and (iv) to use the loans obtained under
          the Credit Facility for the purpose of financing the
          acquisition of General Medical and working capital
          purposes related to the acquisition.


          Item 7(c) - Exhibits.

             2.1    Agreement and Plan of Merger, dated as of
                    January 28, 1997, by and among General Medical
                    Inc., McKesson Corporation, Spider Acquisition
                    Corporation and certain stockholders named
                    therein, (Incorporated by reference to the
                    Current Report of Form 8-K, dated February 5,
                    1997, filed by McKesson Corporation (File No.
                    1-13252)).



                                  SIGNATURES

                    Pursuant to the requirements of the Securities
          Exchange Act of 1934, the registrant has duly caused this
          report to be signed on its behalf by the undersigned
          hereunto duly authorized.

                                        GENERAL MEDICAL CORPORATION
                                        (Registrant)


          Date:  March 5, 1997          By: /s/ Donald B. Garber
                                           -------------------------
                                        Name: Donald B. Garber
                                        Title: Senior Vice President
[{"type": "8-K", "sequence": "1", "description": "8-K", "secsgml_size_bytes": 7983}]
{"company-data": {"conformed-name": "GENERAL MEDICAL CORP /VA", "cik": "0000880123", "assigned-sic": "5122", "irs-number": "942640465", "state-of-incorporation": "VA", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "033-69874", "film-number": "97551807"}, "business-address": {"street1": "8741 LANDMARK RD", "city": "RICHMOND", "state": "VA", "zip": "23228", "phone": "8042647500"}, "mail-address": {"street1": "8741 LANDMARK RD", "city": "RICHMOND", "state": "VA", "zip": "23228"}}
SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                                   FORM 8-K
                                CURRENT REPORT

                    Pursuant to Section 13 or 15(d) of the
                        Securities Exchange Act of 1934

                              February 21, 1997
                      (Date of Earliest Event Reported)

                          GENERAL MEDICAL CORPORATION
            (Exact name of registrant as specified in its charter)

              Delaware                    33-69874           94-2640465
     (State or other jurisdiction     (Commission File     (IRS Employer
          of incorporation)                Number)        Identification
                                                              Number)

                 8471 Landmark Road, Richmond, Virginia 23228
        (Address of principal executive offices, including Zip Code)

                                (804) 264-7500
             (Registrant's telephone number, including area code)

          Item 1 - Change in Control of Registrant.

                    Pursuant to an Agreement and Plan of Merger,
          dated as of January 28, 1997 (the "Merger Agreement"), by
          and among General Medical Inc., a Delaware corporation
          ("General Medical"), McKesson Corporation, a Delaware
          corporation ("McKesson"), Spider Acquisition Corporation,
          a Delaware corporation and a wholly owned subsidiary of
          McKesson ("Merger Sub"), and certain stockholders of
          General Medical named therein (the "Continuing
          Stockholders"), Merger Sub has been merged with and into
          General Medical (the "Merger"), with General Medical as
          the surviving corporation in the Merger.  The Merger,
          which became effective on February 21, 1997, may be
          deemed to constitute a change in control of the
          Registrant, which is an indirect wholly-owned subsidiary
          of General Medical.  A copy of the Merger Agreement is
          filed herewith as Exhibit 2.1 and is incorporated herein
          by reference.

                    Pursuant to the Merger, each share of General
          Medical held by the Continuing Stockholders formerly
          representing the shares of General Medical common stock,
          par value $.01 per share (the "Common Stock") and/or the
          shares of Class A Common Stock, par value $.01 per share
          (the "Class A Common Stock" and together with the Common
          Stock, the "Shares"), was converted in the Merger into
          the right to receive (i) 0.289 shares of the common
          stock, par value $.01 per share of McKesson, together
          with the associated Preferred Stock Purchase Rights of
          McKesson (collectively the "McKesson Common Stock"); (ii)
          an amount in cash equal to $11.934; (iii) the
          Distribution Amount (as determined in the Merger
          Agreement) upon the distribution thereof in accordance
          with the Merger Agreement and (iv) any cash in lieu of
          fractional shares of McKesson Common Stock as provided in
          the Merger Agreement (the foregoing being collectively
          referred to as the "Merger Consideration"), subject to
          the terms and conditions of the Merger Agreement.

                    Each share of General Medical held by the
          stockholders who were not parties to the Merger Agreement
          (the "Non-Continuing Stockholders") formerly representing
          the General Medical Shares was converted into the right
          to receive (i) an amount in cash equal to $29.807 and
          (ii) the Distribution Amount (as defined in the Merger
          Agreement) upon the distribution thereof in accordance
          with the Merger Agreement, subject to the terms and
          conditions of the Merger Agreement.

                    The Distribution Amount, which is non-
          transferable, relates to $30 million of the cash
          consideration which was held back from the General
          Medical shareholders and optionholders to be applied
          against certain costs incurred by General Medical and
          certain other defendants in connection with a pending
          lawsuit involving General Medical.

                    McKesson paid approximately $347 million for
          the equity of General Medical, approximately fifty
          percent of which was in the form of 2,791,738 shares of
          the common stock of McKesson, with the balance paid in
          cash.  In addition, McKesson assumed approximately $428
          million in debt.  In connection with the acquisition,
          McKesson entered into a revolving credit facility (the
          "Credit Facility") with Bank of America National Trust
          and Savings Association (the "Bank"), dated February 21,
          1997.  Subject to the terms and conditions of the Credit
          Facility, McKesson may borrow an aggregate amount not
          exceeding $525,000,000 for the purpose of financing the
          acquisition of General Medical and working capital
          purposes related to the acquisition.  The Credit Facility
          will terminate on the earlier to occur of (i) the date
          which is 180 days after the date on which all conditions
          precedent set forth in the Credit Facility are satisfied
          or waived, and (ii) the date on which the commitment
          terminates in accordance with the provisions of the
          Credit Facility.  The Credit Facility also provides that
          each loan shall bear interest at a rate per annum equal
          to the Offshore Rate or the Base Rate, as the case may
          be, plus the Applicable Margin (as such terms are defined
          in the Credit Facility).

                    The Credit Facility contains certain covenants,
          including covenants obligating McKesson (i) to comply
          with the covenants set forth in a certain Credit
          Agreement dated as of November 4, 1996, among McKesson,
          the financial institutions party thereto, The Chase
          Manhattan Bank, and the Bank, as may be modified and
          amended, (ii) to reimburse and compensate the Bank for
          certain costs and expenses incurred under the Credit
          Facility, (iii) not to deduct any foreign taxes from any
          payments it makes to the Bank, under certain
          circumstances, and (iv) to use the loans obtained under
          the Credit Facility for the purpose of financing the
          acquisition of General Medical and working capital
          purposes related to the acquisition.

          Item 7(c) - Exhibits.

             2.1    Agreement and Plan of Merger, dated as of
                    January 28, 1997, by and among General Medical
                    Inc., McKesson Corporation, Spider Acquisition
                    Corporation and certain stockholders named
                    therein, (Incorporated by reference to the
                    Current Report of Form 8-K, dated February 5,
                    1997, filed by McKesson Corporation (File No.
                    1-13252)).

                                  SIGNATURES

                    Pursuant to the requirements of the Securities
          Exchange Act of 1934, the registrant has duly caused this
          report to be signed on its behalf by the undersigned
          hereunto duly authorized.

                                        GENERAL MEDICAL CORPORATION
                                        (Registrant)

          Date:  March 5, 1997          By: /s/ Donald B. Garber
                                           -------------------------
                                        Name: Donald B. Garber
                                        Title: Senior Vice President